MedTrace Logo

Cognitive Dysfunction in Parkinson's Disease

NCT02346708 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2021-02-09

Study results available
· View outcomes & findings →

Summary

This study plans to learn more about the brain function related to thinking problems in individuals with Parkinson's disease.

Conditions

Interventions

DEVICE

Real TMS

real treatment

DEVICE

Sham TMS

placebo treatment

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Benzi M Kluger, MD, MS · University of Colorado School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2018-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02346708 on ClinicalTrials.gov